Coordination complexes with redox active metal centers are gaining interest for their potential uses in anti-cancer research. KP1019 and NAMI-A are two ruthenium(III) coordination complexes with indazole and dimethylsulfoxide ligands, respectively, that are currently in phase II clinical trials for their anti-tumor or antimetastatic properties. Utilizing a more abundant, less expensive cobalt metal center in place of ruthenium(III), we hypothesize...